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Correlation of Undercarboxylated Osteocalcin (ucOC) 
Concentration and Bone Density with Age in Healthy Korean 
Women
Uncarboxylated osteocalcin (ucOC) is important in evaluating vitamin K status and it is 
inversely associated with bone mineral density (BMD). We studied the correlationship 
between ucOC and BMD in healthy Korean women. This study recruited 337 healthy 
women between ages 20-70 were recruited. Serum ucOC, calcium, alkaline phosphatase, 
body mass index (BMI), and BMD were measured and compared. Mean BMI was lowest 
(20.3±1.9 kg/m
2) in the 20 yr old group and highest (24.8±2.6 kg/m
2) in the 60 yr old group. 
Women age 20-70 yr old had ucOC inversely related to BMD independent of other factors 
that may influence BMD. Serum ucOC concentration and BMD of lumbar spine showed a 
significant inverse relationship. Serum mean alkaline phosphatase was lowest (122±30 IU/L) 
in the age 30 group and highest (190.3±55.8 IU/L) in the age 60 group. Serum ucOC was 
inversely associated with BMI, and positively associated with alkaline phosphatase. 
Uncarboxylated osteocalcin (ucOC) was inversely associated with spinal BMD in healthy 
Korean women. Serum mean ucOC was highest in the age 20 group, followed by age 50 
group, which may indicate vitamin K insufficiency could be related to high bone turnover 
in these groups. These results suggest that vitamin K supplement may be considered to help 
both bone growth and bone loss during these periods. 
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INTRODUCTION
Osteoporosis is the most frequently observed in bone metabol-
ic diseases, which results in a higher risk of bone fracture (1). As 
the average life expectancy increases, the diagnosis of osteopo-
rosis and the cost of the treatment have also increased (2). While 
the lifetime risk of fracture is 13 percent for males, it reaches 40 
percent in females (1, 3). 
  Osteocalcin, a vitamin K-dependent protein that exists abun-
dantly in bone, is synthesized by osteoblast in bones when bone 
stroma forms. A small amount of osteocalcin is released to the 
bloodstream; thus, blood osteocalcin concentration represents 
the activity of osteoblast and bone formation (4). In many clini-
cal studies, the blood osteocalcin level has been used as an in-
dicator for bone formation in various bone metabolic diseases 
(5, 6). 
  Recent studies have shown that vitamin K is necessary in γ- 
carboxylation where osteocalcin combines with minerals. Vita-
min K acts as a coenzyme of γ-carboxylase, which converts glu-
tamate in osteocalcin into γ-carboxyglutamate (Gla) (7). It is clear 
that vitamin K is an essential component in ossification (8, 9). 
Undercarboxylated osteocalcin (ucOC) has been used as hip frac-
ture indicator, since it is related to vitamin K and the observed 
amount of ucOC increases in osteoporosis patients (6, 10). Many 
studies have shown that bone mineral density (BMD) and ucOC 
concentration are inversely related: ucOC concentration increas-
es in female patients with hip fracture as they age (11). There-
fore, ucOC is not only an indicator for ossification and osteoly-
sis, but it is also an index of bone health in females.
  Compared to other countries, there have been no studies pub-
lished in Korea that measure the serum ucOC concentration. 
Thus, our research group has measured the ucOC concentration 
of healthy females ranging from 20 to 80 yr in age to confirm the 
relationship between serum ucOC concentration and BMD.  
MATERIALS AND METHODS
Subjects
Among the women who visited the comprehensive medical test-
ing center at a hospital in Seoul, 337 women between the ages 
of 20 to 80 yr were recruited from March 2007 to June 2008 after 
written informed consent. Patients who had been administered 
hormonal replacement therapy and drugs that may influence 
bone metabolism (bisphosphonate, calcitonin, steroid, phenyt-
oin, carbamazepine, rifampicin etc.) were excluded from this 
study. Patients who had been administered vitamin K metabo-Kim S-M, et al.  •  Undercarboxylated Osteocalcin and Bone Density
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lism-related drugs such as heparin and warfarin, as well as pa-
tients with other metabolic bone diseases were also excluded. 
Institutional Review Board of CHA hospital approved this study 
(EKI-GLA-06-32).
Data collection and method of measurement
All patients’ height and weight information was collected to com-
pute the body mass index (BMI). All blood sampling was com-
pleted in the morning after 10 hours of fasting. Total cholesterol, 
triglyceride, high density lipoprotein cholesterol, and low den-
sity lipoprotein cholesterol were measured by enzymatic colo-
rimetric assay (HITACHI 7600, Tokyo, Japan). BMD of spine and 
hip was measured by QDR 4500 (HOLOGIC, Waltham, USA). 
The serum ucOC concentration was assayed by an enzyme-
linked immunosorbent assay (ELISA) using two monoclonal 
antibodies, an anti-OC antibody and a solid-phase anti-Glu 21, 
24-OC antibody, with recombinant human ucOC (Biotechnol-
ogy Research Laboratory, Takara Shuzo Co., Otsu, Shiga, Japan). 
The intra- and inter-assay coefficients of variation (CVs) were 
7.3% and 9.7%, respectively, and the sensitivity of the assay was 
0.5 ng/mL. The ucOC concentration was measured twice per 
visit and the average value was recorded.
Analysis
Mean and standard deviation of each variable measured from 
the patients was reported. Partial correlation computation was 
used to calculate the correlation coefficient between serum 
ucOC concentration and bone mineral density, and menopaus-
al period, age, body weight and triglyceride have been incorpo-
rated to adjust the values. P values less than 0.05 were statisti-
cally significant; however, P values between 0.05 and 0.10 were 
regarded to be borderline significant. All statistical analysis was 
computed with SPSS 13 (SPSS, Chicago, IL, USA).
RESULTS
General characteristics of the study subjects 
There were 337 patients between 20 to 80 yr of age and each age 
group had 60 patients 37 patients in the 70s. The average age, 
ucOC concentration, total cholesterol, triglyceride, calcium con-
centration and BMI were 47.79±15.86 yr old, 2.018±1.580 ng/mL, 
191.70±34.87 mg/dL, 114.59±61.62 mg/dL, 9.08±0.37 mg/dL, and 
22.66±2.87 kg/m
2, respectively (Table 1).
Serum ucOC, triglyceride, BMI and BMD of each age group
Serum ucOC was highest in the age 20s and decreased until the 
age 50s. However, it increased again in the age 50s, when meno-
pause starts, and then continuously declined. Triglyceride and 
BMI increased and BMD decreased As age increased (Table 2).
Serum ucOC level and BMD
Serum ucOC concentration and BMD of spine from L1 to L4 
showed a significant inverse relationship (P<0.01). BMD of hip 
was borderline significant with r=-0.108, P=0.052 at the neck 
Table 2. Serum ucOC level, triglyceride and body mass index by age-group
Variables 20-29 yr (n=35) 30-39 yr (n=40) 40-49 yr (n=45) 50-59 yr (n=71) 60-69 yr (n=76) 70-79 yr (n=70)
ucOC (ng/mL)   2.59±1.98   1.87±1.35   1.58±1.21   2.24±1.54   1.91±1.71    1.84±1.33
BMDL (g/cm
2)   0.97±0.12   0.99±0.11   0.96±0.10   0.86±0.13   0.78±0.12   0.74±0.12
BMDN (g/cm
2)   0.79±0.10   0.77±0.10   0.76±0.08   0.70±0.08   0.62±0.09   0.57±0.08
BMDW (g/cm
2)   0.77±0.15   0.70±0.13   0.68±0.15   0.57±0.14   0.46±0.15   0.37±0.12
ALP (IU/L) 130.4±15.3 122.3±30.1 140.5±25.7 167.3±45.7 190.3±55.8 178.4±37.8
TG (mg/dL)   86.30±61.79   86.28±38.32 115.17±61.90 124.84±57.26 136.81±55.82 157.24±66.43
BMI (kg/cm
2) 20.33±1.87 21.46±2.44 22.37±2.42 23.45±2.66 24.77±2.56 24.12±2.70
Data are mean±standard deviation.
UcOC, undercarboxylated osteocalcin; BMI, body mass index; TG, triglyceride; BMD, bone mineral density; BMDL, lumbar bone mineral density; BMDN, bone mineral density of 
neck of hip bone; BMDW, bone mineral density of ward of hip bone. 
Table 1. Baseline characteristics of study subjects 
Variables Mean±Standard deviation
Age (yr)     47.79±15.86
Height (cm) 157.87±6.15
Weight (kg)   56.35±6.77
S.B.P (mm/Hg)   111.55±16.98
D.B.P (mm/Hg)     70.67±11.08
BMI (kg/cm
2)   22.66±2.87
Mean lumbar BMD (g/cm
2)     0.897±0.153
BMDNeck (g/cm
2)     0.709±0.120
BMDWard (g/cm
2)     0.609±0.192
Calcium (mg/dL)     9.08±0.37
Total cholesterol (mg/dL)   191.70±34.87
Triglyceride (mg/dL)   114.59±61.62
UcOC (ng/mL)     2.02±1.58
Data are mean±standard deviation.
S.B.P, Systolic blood pressure; D.B.P, Diastolic blood pressure; BMI, Body mass index; 
UcOC, Undercarboxylated Osteocalcin; BMD, Bone Mineral density; BMDNeck, BMD of 
femur neck; BMDWard, BMD of femur ward.
Table 3. Correlation between serum ucOC level and BMD of spine and hip
BMD 
UcOC
r P
Lumbar  -0.209 <0.001
Neck (Hip) -0.108   0.052
Ward (Hip) -0.099   0.073
Controlled for age, body weight, menopausal period and triglyceride.
r, correlation coefficient; BMD, bone mineral density.Kim S-M, et al.  •  Undercarboxylated Osteocalcin and Bone Density
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and r=-0.099, P=0.073 at the ward triangle. Serum ucOC concen-
tration and triglyceride showed no significant correlation with 
r=0.047, P=0.394 (Table 3).
DISCUSSION
Korean women at the age 20–70 yr old demonstrated an inverse 
relationship between ucOC and BMD independent of other fac-
tors that may influence BMD. Serum ucOC concentration and 
BMD of spine from L1 to L4 showed a significant inverse rela-
tionship. BMD of hip was inversely related with serum ucOC 
concentration with borderline significance. Serum mean alka-
line phosphatase was lowest (122±30 IU/L) in the age 30 group 
and highest (190.3±55.8 IU/L) in the age 60 group. Serum ucOC 
was inversely associated with BMI and lumbar spine BMD, and 
positively associated with alkaline phosphatase. Serum mean 
ucOC was highest in the age 20 group, then the age 50 group, 
which may indicate vitamin K might be related to bone turnover 
in these age groups.
  Vitamin K was discovered by Danish scientist, Henrik Dam 
in 1929. Coagulation was thought to be the only known function 
of vitamin K for decades; however, recent studies revealed the 
vital function of vitamin K in bone metabolism. Vitamin K defi-
ciency is related to increased serum ucOC concentration, low 
BMD, and increased risk of bone fracture. Daily recommended 
requirements of vitamin K can be estimated based on the need 
for coagulation and most people can acquire sufficient amount 
of vitamin K from each meal. Nevertheless, the required amount 
for coagulation is smaller than that for bone metabolism (12).
  Nutritional insufficiency of vitamin K, which is often observed 
at old ages, can be a risk factor for osteoporotic hip fracture. Many 
researchers have stated that calcium and vitamin D is effective 
in maintaining bone density and reducing bone fracture (13), 
in addition, recent researches have reported that vitamin K is 
important for osteoporosis and bone health (9, 14).
  When vitamin K concentration in the body is low, insufficient 
amount of osteocalcin completes γ-carboxylation; consequent-
ly, ucOC concentration increases and the affinity to calcium to 
bone matrix decreases. Gla-residues of osteocalcin combine 
with calcium and require vitamin K to activate the reaction site. 
Therefore, measuring ucOC concentration is a more accurate 
method of monitoring vitamin K than prothrombin in the liver 
(15). Vitamin K taken from a regular meal cannot reach the full 
carboxylation of osteocalcin (16) and short term vitamin K insuf-
ficiency can increase the bone turnover rate (17). Many epide-
miology researchers have reported that vitamin K is related to 
hip fracture, BMD and ultimately the healthy bone (18). Thus, 
vitamin K intake can reduce fracture from osteoporosis (9).
  It has been reported that insufficient vitamin K in elderly pa-
tients will increase the risk of hip fracture (19). Weber et al. (20) 
reported that minute vitamin K insufficiency will cause osteo-
porosis. According to the results in this study, the ucOC con-
centration of each age group was 2.59 ng/mL, 1.87 ng/mL, 1.58 
ng/mL, 2.24 ng/mL, 1.91 ng/mL, 1.84 ng/mL, marking age 20s 
(2.6 ng/mL) and age 50s (2.2 ng/mL) at the highest. In other 
words, a considerable amount of vitamin K is needed at the 20s, 
where bone formation is rapid, and the 50s, when the bone turn-
over rate increases at the early menopausal state. Nimptsch et 
al. have shown similar results of ucOC concentration for each 
age group (21).
  Sokoll et al. (22) have reported parallel results that ucOC con-
centration decreases from age 20s to 50s, and increases again at 
age 50s to 60s and then levels off. Women who are able to be preg-
nant (ages 20 to 49) in Thailand showed an average ucOC level 
of 2.69 ng/mL, which has no significant difference from the 2.01 
ng/mL of this study (23).
  Yashui et al. (24) have reported a rapid increase of ucOC con-
centration after removing the ovaries, which simultaneously 
represents the increased ucOC concentration at the early meno-
pausal period. Therefore, ucOC concentration is related with 
age (25), and it abruptly increases at the early menopausal state. 
Moreover, ucOC concentration is an accurate indicator of bone 
quality (26), thus, women whose ucOC concentration increases 
after menopause should closely monitor their bone turnover 
rate and BMD. In Yashui et al., the serum ucOC concentration 
of Japanese between 30 to 80 yr of age was positively related to 
age and the patients’ BMI, and serum triglyceride level was lower 
at older ages. In our study, ucOC concentration decreased until 
age 50s and increased thereafter, and then continued to decrease. 
The BMI and serum triglyceride level of our study subjects were 
significantly higher at older ages. Consequently, the serum ucOC 
of Japanese study increased with age, but not in Koreans, because 
of their body fat and serum triglyceride level. Serum triglyceride 
is thought to be the main vehicle that carries vitamin K into the 
bloodstream. A recent study showed significantly lower ucOC 
concentration in menopausal women who received hormonal 
replacement therapy than menopausal women who did not (27). 
The hormonal replacement therapy increased the triglyceride 
and further increased vitamin K absorption, which decreased 
ucOC concentration (30).
  Schurgers et al. (28) stated that triglyceride is a major vitamin 
K carrier, and other researches show a positive relationship be-
tween vitamin K concentration and the triglyceride amount in 
body (17). Our results have showed increased BMI and triglyc-
eride concentration at older ages which is identical to the results 
of Chang et al. where the total cholesterol and triglyceride amount 
increases as age, time after menopause, and BMI increase (29). 
Therefore, weight gaining increases triglyceride and affects ucOC 
concentration. In addition, ucOC concentration varies with the 
seasons (summer being the lowest), as well as other daily living 
habits: smoking, activity level, diet of leafy green vegetables and 
dairy products (21). Nonetheless, the correlation between serum Kim S-M, et al.  •  Undercarboxylated Osteocalcin and Bone Density
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ucOC concentration and triglyceride has not been observed in 
our study. 
  The ucOC concentration and BMD of spine showed a statis-
tically significant negative relationship, while BMD of hip was 
only borderline significant. However, Szulc et al. (11) have shown 
a definite negative relationship between ucOC concentration 
and hip BMD, and other studies confirmed a relationship be-
tween decreased bone density and serum ucOC concentration 
in menopausal women (30). Szulc et al. (11) states that the BMD 
of all bones shows a negative relationship with ucOC concentra-
tion. According to other researchers, ucOC concentration has 
shown to have a stronger relationship with quality of the bone 
than the density (14, 15), and thus, ucOC is an accurate indica-
tor for hip fracture in aged patients (11, 13).
  Consequently, vitamin K may become insufficient at the 20s, 
when bone turnover rate is the fastest, and the 50s, when meno-
pause starts, as represented by high ucOC concentration. Vita-
min K is closely related to the risk of fracture and increased bone 
formation; thus, vitamin K may be recommended for osteopo-
rosis and bone fracture treatment.
  Our study has some limitations that the collected patients did 
not represent the total population because they visited a partic-
ular hospital for health examinations, and only a small number 
of over 70-yr-old patients were able to participate in the study. 
We did not examine Vitamin K concentration. Also, other factors 
that can affect vitamin K metabolism such as smoking, alcohol, 
diet, exercise, and vitamin D absorption were not incorporated 
as a correction value. Although statistically strong correlation 
was not shown, it is still compelling, since we have measured 
ucOC concentrations and other influential factors to monitor 
the vitamin K condition of Korean women and suggested fur-
ther research of osteoporosis and risk of fracture in elderly pa-
tients in respect to ucOC concentration. 
  In conclusion, ucOC was inversely associated with spinal BMD 
in healthy Korean women. There were two significant age groups 
when they had high serum ucOC concentrations at the 20s and 
at the 50s. This result suggest that vitamin K supplement may 
improve both bone growth and bone loss at these ages. 
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